other
confidence low
sentiment neutral
materiality 0.15
Armata presents at H.C. Wainwright conference; no new data in exhibit
Armata Pharmaceuticals, Inc.
- CEO Dr. Deborah Birx presented at H.C. Wainwright 27th Annual Global Investment Conference on Sept 10, 2025.
- Exhibit 99.1 contains only title slide and forward-looking disclaimers; no new clinical or financial data.
- Prior $26.2M DoD award referenced in disclaimers; no update on program milestones or guidance.
item 7.01item 9.01
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.